Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-01-02 Sale | 2020-01-03 4:01 pm | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 11,294 | $15.04 | $169,817 | 233,135 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-02-11 Option Award | 2021-02-16 5:48 pm | N/A 2031-02-10 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR See Remarks | 72,500 | $0 | 72,500 (Direct) | View |
2020-04-14 Option Award | 2020-04-16 4:52 pm | N/A 2030-04-13 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR See Remarks | 50,000 | $0 | 50,000 (Direct) | View |
2020-02-10 Option Award | 2020-02-12 5:19 pm | N/A 2030-02-09 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 104,000 | $0 | 104,000 (Direct) | View |
2020-01-02 Exercise | 2020-01-03 4:01 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 11,294 | $9.49 | 233,135 (Direct) | View |
2020-01-02 Exercise | 2020-01-03 4:01 pm | N/A 2028-04-25 | Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer | 11,294 | $0 | 233,135 (Direct) | View |